Microscopy & Microtechniques
Easing the way for pain-free insulin injections
Mar 13 2006
Author: Matthew Williamson, Novo Nordisk and Chris Keeping on behalf of Novo Nordisk A/S
There are an estimated 194 million diabetics worldwide and at the present rate of growth, this figure will exceed 333 million by 2025 [1]. Since some 17 million of the 194 million suffer from Type 1 diabetes and rely on regular injections of insulin, there is continuous effort by manufacturers of insulin delivery devices and needles to minimise the pain associated with these vital injections. Materials testing methods have an important role in ensuring that needles and needle assemblies meet the needs for safe handling and easy, pain-free injection.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 22 2024 Marrakech, Morroco
Making Pharmaceuticals Exhibition & Conference
Apr 23 2024 Coventry, UK
Apr 23 2024 Kintex, South Korea
Apr 23 2024 Seoul, South Korea
Apr 24 2024 Jakarta, Indonesia